BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  RIBOMIC Announces Positive Top-Line Results from the Phase 1/2a Clinical Trial of RBM-007 (SUSHI Study) in Subjects with Wet Age-Related Macular Degeneration

  RBM-007 was well-tolerated with no dose-limiting toxicities, no systemic or ocular serious adverse events.

  June 17, 2019

   · 

  6 min read
• BioCapital

  Microbiome Therapeutics Innovation Group Statement on FDA Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms

  On June 13, 2019, the U.S. Food and Drug Administration (FDA) issued a safety alert regarding the use of fecal microbiota for transplantation,

  June 17, 2019

   · 

  5 min read
• Biotech Beach

  Couple Aims to Break the Silence

  Thane and Cynthia Murphy of Assuaged, Inc. are no strangers to physical and mental challenges. Thane, a Marine Corps veteran, has Post-Traumatic Stress Disorder (PTSD) as a result of the brain injury he suffered during active duty.

  June 17, 2019

   · 

  2 min read